ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2021

[Lorlatinib: a promising drug in the future treatment of advanced ALK-positive non-small-cell lung cancer].

Johanna Richter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.